Zacks Small Cap Research – NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox
By David Bautz, PhD NYSE:NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface structures to trap and dismantle viruses before they infect host cells. The company’s lead development candidate, NV-387, has shown promising preclinical activity against multiple viruses, including […]
B2Gold Announces Positive Feasibility Study Results for the
After-Tax NPV (5%) of $941 Million with an After-Tax IRR of 22.4% at $2,500 / ozAfter-Tax NPV (5%) of $1,716 Million with an After-Tax IRR of 33.5% at Spot Gold ($3,300 / oz) VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) […]
Mogotes Metals Announces Closing of Third and Final Tranche of Private Placement of Units
July 14, 2025 7:00 AM EDT | Source: Mogotes Metals Inc. Toronto, Ontario–(Newsfile Corp. – July 14, 2025) – Mogotes Metals Inc. (TSXV: MOG) (FSE: OY4) (OTCQB: MOGMF) (“Mogotes“, or the “Company“) is pleased to announce that, further to its press releases of June 2, 2025, June 16, 2025 and July 7, 2025, the […]